Kangaroo Care: Breastfeeding Success and Maternal Role
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-49
SponsorRecep Tayyip Erdogan University
About this trial
Purpose: This is a randomized controlled trial designed to investigate the effects of Kangaroo Mother Care (KMC) applied in the early postpartum period to primiparous mothers on breastfeeding success and the perception of the maternal role.
Methodology and Sample:
Setting and Period: The study will be conducted at the Bucak State Hospital Delivery Unit between June 2025 and June 2026.
Sample Size: Based on G\*Power analysis (alpha=0.05, power=80%, effect size d=0.566), a total of 112 mothers (56 intervention, 56 control) will be included, accounting for a 10% potential attrition rate. Participants will be assigned to groups using the sealed envelope method and randomization via www.random.org.
Intervention:
Experimental Group: Following routine care, the newborn will be placed in a "chest-to-chest" position on the mother's bare chest for Kangaroo Care. Intermittent KMC will be maintained for 24 hours, during which breastfeeding attempts will be supported.
Control Group: Mothers and newborns will receive only the hospital's routine care (standard skin-to-skin contact and breastfeeding support).
Data Collection Tools:
Personal Information Form, Semantic Differential Scale-Myself as a Mother (to measure maternal role perception), LATCH Breastfeeding Assessment Tool (to evaluate breastfeeding success).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
It must be the mother's first birth,
Birth must have been vaginal,
The mother must be healthy,
The mother must voluntarily participate in the study,
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Kangaroo Mother Care
BehavioralNewborns will be placed in an upright chest-to-chest position on the mother's bare chest. This intermittent skin-to-skin contact will be applied in sessions according to the mother's and newborn's stability and comfort, and will be maintained at regular intervals throughout the first 24 hours postpartum.
Treatment groups
112 Participants
are divided into 2 treatment groupsGroup A: KangarooExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
LATCH Breastfeeding Assessment Tool
Developed by Deborah Jehsen and Sheila Wallace in 1993 to assess breastfeeding, it consists of five parameters, each item scored between 0 and 2 points. The highest possible score on the scale is 10, and the lowest is 0. The validity and reliability of the LATCH Breastfeeding Assessment Tool in Turkey was determined by Yenal and Okumuş in 2003, and it was found to be valid and reliable for the Turkish population. The validity and reliability coefficient of the LATCH scale is alpha 0.82. The scale, consisting of 5 evaluation criteria, is formed by combining the first letters of the English words LATCH. The criteria are as follows; L: Latch on breast A: Audible swallowing T: Type of nipple C: Comfort breast/nipple. H: Baby holding position
Time frame
8 month2
Semantic Difference Scale - Self-Assessment as a Mother
Developed by Walker et al. (1986), this scale was designed to measure the evaluation dimensions of the concept of "self-assessment as a mother." The adaptation of the scale to Turkish society was done by Çalışır (2003). The scale consists of 11 pairs of opposing adjectives, distributed among 22 items. Each adjective pair is scored from 1 to 7. Three items (3, 7, 8) are evaluated using a reverse scoring system to prevent biased scoring by participants. A high total score on the scale indicates a positive self-assessment of motherhood (Walker et al., 1986). While Walker found the internal consistency coefficient to be between 0.81-0.85, Çalışır found the Cronbach Alpha internal consistency coefficient to be between 0.73-0.74 (Çalışır, 2003).
Time frame
8 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov